2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - (Page 10) psychiatric hospital as part of a multidisciplinary UniversityState Hospital affiliation. This has included psychiatry, nursing, psychiatric rehabilitation, and social work and the introduction of programs such as Illness Management and Recovery, Nurse Directed Care, Therapeutic Communication, a discharge-oriented Therapeutic Alliance group model, and community interface initiatives. The proposed workshop will explore issues and challenges relating to integrating these themes and approaches as well as implications for general psychiatric practice. By participating in this activity, attendees will be able to: 1) List principles and practices associated with Recovery and wellness as it relates to psychiatric settings 2) Identify methods for using wellness and Recovery principles to enhance the therapeutic alliance and efficacy of treatment, including for persons perceived as “resistant” to treatment and to community living; and 3) Describe methods to enhance collaborative relationships with community residential and clinical support providers. and their staff; 2) Describe the trajectories involved in cancer, and the patient’s needs at each stage; and 3) Express the suitability of cognitive therapy as a framework for helping a patient deal with issues raised by a diagnosis of cancer. 17-8 Systems Neuropsychiatry, Part 2: The Decade of the Mind and the Future of Clinical Psychiatry NP 17-3 The Ultimate Personal and Professional Challenge: How to Improve Comfort and Competence with Medical DecisionMaking Near the End-of-Life GP PI The treatment of psychiatric disorders and the promotion and protection of mental health are pivotal to the upcoming 2010 – 2020 “Decade of the Mind” (see Systems Neuropsychiatry, Part 1: The Decade of the Mind), as are the notions of understanding, enriching, and modeling the mind. Consequences for clinical psychiatry of the ‘Decade of the Mind” are elaborated upon in the second of this two part seminar. By participating in this activity, attendees will be able to: 1) Describe how cognitive neuropsychiatry becomes the framework for psychiatry in a “Decade of the Mind”; 2) Identify the challenges and opportunities that this new paradigm offers psychiatric diagnosis, treatment planning, treatment and prevention; and 3) Express how “learning” a transdisciplinary approach, which characterizes best practice in the Decade of the Mind, is beneficial to practice. conditions which present primarily with psychiatric or behavioral symptoms. The conditions included in this category range from neurological disorders (e.g. seizure disorders and MS), to infectious diseases (e.g. syphilis, herpes and HIV), to connective tissue disorders (e.g. vasculitis and SLE), to malignancies (e.g., paraneoplastic syndromes and pancreatic cancer), to metabolic disorders (e.g. wilson’s disease and prophyria), to various toxins and substances our patients may be exposed to. In this lecture, we will discuss the presentation and symptoms of the most common masquerades, focusing on pearls for timely diagnosis, and discuss potential management and treatment strategies. By participating in this activity, attendees will be able to: 1) Recognize the most common infectious disorders presenting with psychiatric symptoms; 2) Explain the incidence, epidemiology and clinical features of the most common neuropsychiatric disorders masquerading as psychiatric illness; 3) Recommend the research-based, effective treatment options for these conditions. 9:30-10:45 a.m. 22-0 Adult ADHD PD PT Supported by an educational grant from Eli Lilly and Company. The end of a person's life can be one of the most important times of that life. The purpose of this course is to equip physicians with knowledge, skills and attitudes that can be tailored to their unique practice setting. By participating in this activity, attendees will be able to: 1) Describe how the changing demographics of aging will impact the healthcare system; 2) Identify the factors measured in determining whether patients are competent to make decisions regarding their medical care; and 3) Describe ways to discuss care options with families and caregivers. 3:45-6:45 p.m. Exhibit Hall 7:00-9:00 p.m. 19-0 TBD Dinner Symposium • 1.5 credits 17-4 Neuroleptic Malignant Syndrome RX Friday, Oct. 31 7:00-9:00 a.m. 21-0 Insomnia and Depression Breakfast Symposium • 1.5 credits Supported in part by an educational grant from sanofi-aventis U.S. Inc. Evidence shows that physicians still need to understand many of the complexities in the differential diagnosis of adult ADHD. Issues such as diagnostic challenges in relation to comorbid conditions and decreased functioning and quality of life implications, as well as current strategies and treatment options for the diagnosis and management of adults with ADHD are crucial. By participating in this activity, attendees will be able to: 1) Identify confounders that complicate the diagnosis of adult attention-deficit/hyperactivity disorder; 2) Understand the complexities in the diagnosis of adult ADHD; and 3) Evaluate the efficacy and safety of nonpharmacologic and pharmacologic therapeutic options for the treatment of adult ADHD. This course provides information on NMS diagnosis and treatment based on the most current research. By participating in this activity, attendees will be able to: 1) Recognize the clinical signs of NMS associated with typical and atypical antipsychotics to help determine a diagnosis; 2) Identify related conditions and risk factors associated with the development of NMS; 3) Discuss the differential diagnosis and strategies for the treatment of NMS. 22-1 Practice Management Series 1B: Marketing in Private Practice: Smart Tips Inside and Outside the Psychiatric Office PI 17-5 Should Side Effects Be the Determining Factor in Choosing an Antipsychotic? RX 8:00-9:15 a.m. 21-1 Practice Management Series 1A: Workflow for Enhanced Productivity PI The progressive psychiatric practice wants to enhance productivity without compromising patient service. This presentation will explore ways to manage workflow, make the most of time, and improve productivity—all the while becoming more “patient-centered.” By participating in this activity, attendees will be able to: 1) Adopt a disciplined approach to time management in the medical office; 2) Evaluate simple processes to manage workflow in private psychiatric practice; and 3) Implement protocols that will allow improved productivity while enhancing psychiatric patient service. The choice of the right atypical antipsychotic for an individual patient can be a daunting challenge to most physicians. By participating in this activity, attendees will be able to: 1) Discuss side effects of first-and-second generation antipsychotics; 2) Identify side effect profiles among secondgeneration antipsychotics; and 3) Develop a treatment strategy that includes risk/benefit ratio as a determining factor in choice of antipsychotic. Marketing isn’t just about advertising, and advertising isn’t just about a full page in the phone book or 30 seconds on the radio. This presentation will help private practice psychiatrists fit the concept of marketing into their ideal of patient care. How-tos for both internal and external strategies, including staffing and training, are designed for real-world implementation and practice growth. By participating in this activity, attendees will be able to: 1) Develop effective strategies for increasing community recognition of a private psychiatric practice; 2) Enhance relationships with colleagues and other resources to ensure strong referral streams; and 3) Integrate staffing considerations into marketing decisions for improved patient service. 22-2 17-6 Psycho-Proctology: The Bottom Line RX 21-2 Constipation is a major side effect of many of the pharmacological agents used in psychiatry and is believed to be an anticholinergic side effect. By participating in this activity, attendees will be able to: 1) Discuss the consequences of undertreated, or unrecognized, severe psychiatric drugassociated constipation progressing to fatal bowel obstruction; 2) Recognize the possibilities such as altered sensitivity to pain and difficulty expressing the pain associated with certain psychiatric disorders (e.g., constipation in schizophrenia patients); and 3) Identify guidelines to recognize the symptoms of constipation in psychiatric patients. HOT! Returning Veterans and Exposure to Depleted Uranium: An Update PD SC Pharmacotherapy of Dual-Diagnosis Patients AP RX 17-7 PD PT Cognitive Therapy to Aid Adjustment to Cancer: Where It’s Going— A Preview This course will consider different formats for a psychiatrist working in an oncology setting, leading to a focus on the role of a mental health clinician in a private oncology practice. Cognitive therapy approaches to problems adjusting to cancer at its various stages will be discussed.By participating in this activity, attendees will be able to: 1) Identify ways to succeed in mental health work in a medical setting alongside oncologists Mental health clinicians are being increasingly challenged by patients who believe themselves to have been exposed to radiogenic materials. This session will identify common complaints both of indigenous peoples exposed to unrefined uranium and veterans of the wars in Iraq exposed to munitions laced with depleted uranium. Department of Defense publications and politicians claim there is no health risk to the use of depleted uranium or other radiogenic materials used in combat. By participating in this activity, attendees will be able to: 1) Outline intervention strategies with patients who fear radiogenic exposure; 2) Identify symptoms reported by patients who believe they are the victims of radiogenic exposure; and (3) Examine models of intervention which appear to be effective in assisting patients who fear contamination. The prevalence of coexisting substance misuse and psychiatric disorder (dual diagnosis) http://www.cmellc.com/psychcongress
Table of Contents Feed for the Digital Edition of 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 U.S. Psychiatric & Mental Health Congress Conference & Exhibition Exhibit Hall Opportunities Contents Industry-Supported Symposia Educational Track System Educational Sessions Hosts and Advisory Committee Faculty Presenters About San Diego Discounted Tax-Deductible Tuition 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - U.S. Psychiatric & Mental Health Congress Conference & Exhibition (Page 1) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - U.S. Psychiatric & Mental Health Congress Conference & Exhibition (Page 2) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - U.S. Psychiatric & Mental Health Congress Conference & Exhibition (Page 3) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Contents (Page 4) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Industry-Supported Symposia (Page 5) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Educational Track System (Page 6) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Educational Track System (Page 7) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Educational Sessions (Page 8) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Educational Sessions (Page 9) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Educational Sessions (Page 10) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Educational Sessions (Page 11) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Educational Sessions (Page 12) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Educational Sessions (Page 13) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Educational Sessions (Page 14) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Educational Sessions (Page 15) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Educational Sessions (Page 16) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Hosts and Advisory Committee (Page 17) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Hosts and Advisory Committee (Page 18) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Faculty Presenters (Page 19) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Faculty Presenters (Page 20) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Faculty Presenters (Page 21) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - About San Diego (Page 22) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Discounted Tax-Deductible Tuition (Page 23) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Discounted Tax-Deductible Tuition (Page 24)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.